We therefore conducted this study to explore the effect and molecular mechanism of intravitreally injected fbn2 recombinant protein for the treatment of fbn2-deficiency retinopathy. This evidence concerns the gene FBN2 and hyperinsulinemic hypoglycemia, familial, 4.